CTRI/2022/09/045877尚未招募未知
EFFICACY AND SAFETY OF DESIDUSTAT IN CHILDREN WITH ANEMIA AND CHRONIC KIDNEY DISEASE
AIIMS New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age: 10 to 18 years
- •Chronic kidney disease stage 3 to stage 5
- •Anemia based on age and gender-specific values (KDIGO 2012)
- •Iron-replete state (T sat >20% and Ferritin >100 ng/mL)
- •Normal B12 and folate levels
- •Written informed consent
排除标准
- •1. Anemia due to a cause other than CKD
- •2. CKD on dialysis at enrolment
- •3. Recent PRBC transfusion ( <4 weeks)
- •4. Hyperparathyroidism (iPTH >700 pg/mL)
- •5. Children on ESA with Hb <9 g/dL
- •6. Stage 2 hypertension even on anti-hypertensive medications
- •7. Hypersensitivity to desidustat
研究者
相似试验
已完成
不适用
Clinical evaluation of the effects of paediatric dental general anaesthesia and midazolam sedation on cognitive function, anxiety and access to future dental careDental caries requiring multiple extractionsOral HealthCariesISRCTN12026431Scottish Executive Chief Scientist Office (UK)200
尚未招募
4 期
se of Desidustat or darbepoetin to cure low blood in patients with kidney diseaseCTRI/2023/11/059727Saajid Hameed
尚未招募
2 期
Treatment for autismCTRI/2023/02/050044Impute inc
进行中（未招募）
1 期
Follow-Up study in Previously Treated Children to investigate a new FVIII concentrateEUCTR2011-001785-17-PLOctapharma AG50
进行中（未招募）
1 期
Follow-Up study in Previously Treated Children to investigate a new FVIII concentrateSevere Haemophilia AMedDRA version: 14.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-001785-17-CZOctapharma AG60